<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein is a key component of the extrinsic apoptotic pathway </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, in animal models, Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein phosphorylation at serine 194 has been shown to affect cell proliferation, especially in T lymphocytes </plain></SENT>
<SENT sid="2" pm="."><plain>The importance of Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein phosphorylation at serine 194 for the proliferation of B lymphocytes, however, is uncertain </plain></SENT>
<SENT sid="3" pm="."><plain>Here we show in reactive lymph nodes that serine 194 phosphorylated Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein is expressed predominantly in the dark (proliferative) zone of germinal centers </plain></SENT>
<SENT sid="4" pm="."><plain>In B-cell non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines, serine 194 phosphorylated Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein levels are substantially higher in highly proliferating cells and lower in serum-starved cells </plain></SENT>
<SENT sid="5" pm="."><plain>We also used immunohistochemical analysis to assess Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein phosphorylation at serine 194 expression in 122 B-cell non-Hodgkin-type <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The mean percentage of serine 194 phosphorylated Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells was 81% in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 41% in diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 18% in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 18% in plasma cell <z:mp ids='MP_0009440'>myeloma</z:mp>, 12% in extranodal marginal zone B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of mucosa-associated lymphoid tissue, 11% in mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and 2% in <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (P &lt; .0001, Kruskal-Wallis test) </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, in <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, serine 194 phosphorylated Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein was detected predominantly in proliferation centers </plain></SENT>
<SENT sid="8" pm="."><plain>In the entire study group, the percentage of cells positive for serine 194 phosphorylated Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein correlated significantly with the proliferation index Ki-67 (Spearman R = 0.9, P &lt; .0001) </plain></SENT>
<SENT sid="9" pm="."><plain>These data provide evidence that serine 194 phosphorylated Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein is involved in the proliferation of <z:mpath ids='MPATH_458'>normal</z:mpath> and neoplastic B cells and has features of a novel proliferation marker </plain></SENT>
</text></document>